Have a personal or library account? Click to login
Benefits of administering GLP-1 analogs to patients with polycystic ovary syndrome, considering their effect on adipose tissue metabolism Cover

Benefits of administering GLP-1 analogs to patients with polycystic ovary syndrome, considering their effect on adipose tissue metabolism

Pomeranian Journal of Life Sciences
Volume 69 (2023): Issue 4 (December 2023)
By: Małgorzata Król,  Justyna Żychowska,  Ryszard Łagowski,  Patrycja Kupnicka,  Donata Simińska and  Dariusz Chlubek  
Open Access
|Dec 2023
DOI: https://doi.org/10.21164/pomjlifesci.965 | Journal eISSN: 2719-6313 | Journal ISSN: 2450-4637
Journal RSS Feed
Language: English
Page range: 32 - 37
Published on: Dec 26, 2023
Published by: Pomeranian Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
glucagon-like peptide-1 agonists,
adipose tissue,
obesity,
polycystic ovary syndrome
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Surgery,
Surgery, other,
Public health

© 2023 Małgorzata Król, Justyna Żychowska, Ryszard Łagowski, Patrycja Kupnicka, Donata Simińska, Dariusz Chlubek, published by Pomeranian Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2023): Issue 4 (December 2023)Next article